Skip to main navigation
Ocugen, Inc.
Pursuing Innovative Ocular Biotherapeutics
About
+
Executive Management
Board of Directors
Scientific Advisory Board
Founders
Pipeline
+
Pipeline Overview
OcuNanoE – Ocugen’s ONE Platform™
OCU300
Modifier Gene Therapy Platform
+
OCU400
OCU410
OCU200
OCU100
News
+
Press Releases
News & Events
Investors
-
Investor Overview
Stock Information
+
Historic Price Lookup
Investment Calculator
Analyst Coverage
Financial Information
+
SEC Filings
Annual Reports
Quarterly Results
Presentations
Investor Calendar
Corporate Governance
Investor Resources
+
Investor FAQs
Email Alerts
Contact IR
Fact Sheet
Careers
Contact
Contact
Biography
Prabha Fernandes
Director
Member of the Compensation Committee
